Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 35

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 35
---
�  ], 2025. The Annual Report and other SEC filings may also be accessed at https://sec.gov or on the Investors page of                                                                                                                                                                                                                                                  
 STAAR’s website at https://investors.staar.com/. STAAR’s website address is provided as an inactive textual reference only. The                                                                                                                                                                                                                                                                                                                                      |

-19-

| information contained in, or that can be accessed through, STAAR’s website is not part of this proxy statement and is not incorporated in this proxy statement by this or any other reference 
 to STAAR’s website provided in this proxy statement.                                                                                                                                          |

| Q: | Who can help answer my questions? |

| A: | If you have any questions concerning the Merger, the Special Meeting or the accompanying proxy statement, would                                           
 like additional copies of the accompanying proxy statement or need help voting your shares of STAAR common stock, please contact STAAR’s proxy solicitor: |

INNISFREE M&A INCORPORATED 501 Madison Avenue, 20th Floor New York, New York 10022 Stockholders, please call toll-free: (877) 750-8233 Banks and brokerage firms, please call: (212) 750-5833 -20-

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS The information covered by this proxy statement may contain forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended (which this proxy statement refers to as the “Securities Act”), and Section 21E of the Exchange Act, as amended by the Private Securities Litigation Reform Act of 1995, such as statements about the consummation of the proposed Merger and the anticipated benefits thereof. Forward-looking statements often contain words such as “anticipate,” “believe,” “expect,” “plan,” “estimate,” “project,” “continue,” “will,” “should,” “may” and similar terms. These forward-looking statements do not constitute guarantees of future performance and are subject to a variety of risks and uncertainties that may cause actual results to differ materially from any future results expressed or implied by the forward-looking statements. In addition, STAAR has based some of these forward-looking statements on assumptions about future events that may prove to be inaccurate. Such factors, risks and uncertainties include:

| • |     | the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger            
 Agreement between the parties to the Merger or extend the anticipated timetable for completion